The development of a World Health Organisation international standard for islet cell antibodies: The aims and design of an international collaborative study

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 1, 1999, Pages 72-77

  Mire Sluis, Anthony R ^a   Das, Rose Gaines ^a   Lernmark, Åke ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Assays; Autoantibodies; Islet cell antibodies; Standardisation

Indexed keywords

MARKER; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNATIONAL COOPERATION; ISLETS OF LANGERHANS; LABORATORIES; REFERENCE STANDARDS; WORLD HEALTH ORGANIZATION;

EID: 0032993872     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199901/02)15:1<72::AID-DMRR11>3.0.CO;2-G     Document Type: Article

References (21)

1. Green A, Gale EA, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet 1992; 339: 905-909.
2. Diabetes Epidemiology Research International Group. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 1990; 39: 858-864.
3. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279-1283.
4. Lendrum R, Walker G, Gamble DR. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1975; 3: 880-883.
5. Gorsuch AN, Spencer KM, Lister J. The natural history of type I (insulin-dependent) diabetes mellirus: evidence for a long prediabetic period. Lancet 1981; 2: 1363-1365.
6. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS. Islet cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for type I diabetes mellitus. N Engl J Med 1983; 308: 321-325.
7. Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993; 16: 45-50.
8. Bottazzo GF, Gleichmann H. Workshop report: immunology and diabetes workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 1986; 29: 125-126.
9. Bonifacio E, Dawkins RL, Lernmark A. Immunology and diabetes workshops: report of the second international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 1987; 30: 273.
10. Boitard C, Bonifacio E, Bottazzo GF, Gleishmann H, Molenaar J. Immunology and diabetes workshop: report on the third international (Stage 3) workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 1988; 31: 451-452.
11. Lernmark A, Molenaar JL, van Beers WA, Yamaguchi Y, Nagataki S, Ludvigsson J, Maclaren NK. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories. Diabetologia 1991; 34: 534-535.
12. Bonifacio E, Lernmark Å, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106: 83-88.
13. DPT-1 Study Group: The Diabetes Prevention Trial-Type 1 diabetes (DPT-1): implementation of screening and staging of relatives. Transplant Proc 1995; 27: 3377-3379.
14. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, van Beers WAM, Maclaren NK, Lernmark Å. Improved specificity of ICA assays in Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 1992; 41: 1570-1574.
15. Schmidli RS, Colman PG, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International Glutamic Acid Decarboxylase Workshop. Diabetes 1995; 44: 636-640.
16. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. Combined use of autoantibodies (IA-2ab, GADab, IAA, ICA) in type I diabetes: combinatorial islet autoantibody workshop. Diabetes 1998; 47: 1857-1866.
17. Mire-Sluis AR, Gaines-Das R, Thorpe R. Immunoassays for detecting cytokines - what are they really measuring? J Immunol Methods 1995; 186: 161-164.
18. Gleichmann H, Bottazzo GF. Progress towards standardisation of cytoplasmic islet-cell antibody assay. Diabetes 1987; 36: 578-584.
19. World Health Organisation. Guidelines for the preparation, characterisation and establishment of international and other standards and reference reagents for biological substances. World Health Organisation Technical Report Series 1990; 800: 181-214.
20. European Phamacopoeia. Determination of water. European Pharmacopoeia 1992; F16: V.3.5.6.
21. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350.